NFE2L2 and metabolic dysfunction-associated steatotic liver disease: Existing studies on SFN against NAFLD focused on inhibiting hepatic liposynthesis and steatosis [23,48], improving insulin resistance [21], antioxidant effects after NRF2 activation [49], and protecting mitochondrial functions [22].